A $5 million interest-free loan the Biden family received

New Post Public Reply Private Reply Replies (0) Message Board
dbergh SaltyMutt #106542
213
A $5 million interest-free loan the Biden family received from a Chinese energy conglomerate in 2017 should have been probed by the FBI as part of a possible “pay-to-play” plan, Sen. Chuck Grassley told top law enforcement officials last week.

In an Oct. 13 letter to Attorney General Merrick Garland, FBI Director Christopher Wray and Delaware US Attorney David Weiss, Grassley (R-Iowa) questioned whether the bureau is fully investigating corruption allegations against first son Hunter Biden and demanded a “full and unredacted FBI summary” of Hunter business partner Tony Bobulinski’s October 2020 FBI interview.

According to Grassley, Bobulinski told investigators that Hunter and first brother James Biden were contracted to assist CEFC China Energy “with potential business deals and investments while Joe Biden was Vice President; however, that work remained intentionally uncompensated while Joe Biden was Vice President.

“After Joe Biden left the Vice Presidency, the summary makes clear that Hunter Biden and James Biden worked with CEFC and affiliated individuals to compensate them for that past work and the benefits they procured for CEFC,” Grassley went on. “According to the summary, Hunter Biden, James Biden and their business associates created a joint venture that would serve as a vehicle to accomplish that financial compensation, and that arrangement was made sometime after a meeting in Miami between Hunter Biden and CEFC officials in February 2017.
https://nypost.com/2022/10/18/bidens-5m-china...-grassley/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Merck & Co., Inc. Investors Urged to Take Action Now

Updated Category News Views 131

Important Notice for Merck & Co., Inc. Investors Investors in Merck & Co., Inc. (MRK) are being encouraged to seek legal counsel as we approach a significant deadline related to a securities class action lawsuit. This timeline marks an important opportunity for purchasers of Merck's securities made between February 3, 2022, and February 3, 2025, to secure representation...

Continue Reading
Justice-Impacted Individuals Gaining Access to Education

Updated Category News Views 116

Expanding Opportunities for Justice-Impacted Individuals In a significant initiative aimed at improving the lives of justice-impacted individuals, multiple states are coming together to enhance educational and workforce pathways. This collaborative effort is focused on providing necessary resources and opportunities for individuals who have faced incarceration, aiming to...

Continue Reading
Celebrating Excellence: 2025 Lifetime Achievement Award Recipients

Updated Category News Views 123

Honoring Peter Murray and SawTeen See at the CTBUH 2025 Awards The Council on Tall Buildings and Urban Habitat (CTBUH) has recognized two remarkable figures in the field of architecture and structural engineering for their essential contributions to urban design. Peter Murray, co-founder of New London Architecture, and SawTeen See, a prominent structural engineer, are the...

Continue Reading
Northern Oil and Gas Expands Horizons with Acquisition Talks

Updated Category News Views 145

Northern Oil and Gas Options for Strategic Growth Northern Oil and Gas is actively pursuing acquisition opportunities, specifically targeting Granite Ridge Resources. Based in Minneapolis, this ambitious company has shown intent to enhance its portfolio by considering Granite Ridge, a relatively smaller player in the oil industry, skilled in extracting resources from...

Continue Reading
Invivyd Announces Insights into VYD2311's Clinical Journey

Updated Category News Views 176

Invivyd Hosts Webcast to Discuss the REVOLUTION Program Invivyd, Inc. (Nasdaq: IVVD) will present a live webcast detailing its innovative REVOLUTION clinical program. This event, aimed at both investors and the public, will showcase the company’s promising monoclonal antibody, VYD2311, which serves as a vaccine alternative for COVID-19 prevention. The Overview of...

Continue Reading